Results 91 to 100 of about 12,135 (209)
Sex in Immune Cells and Parasitic Diseases — A Complex Relationship
ABSTRACT Epidemiological studies consistently show that many parasitic diseases affect males more frequently than females. These disparities are multifactorial, arising partly from gender‐specific behaviors that influence exposure risk and health‐seeking practices, especially in low‐ and middle‐income countries. Increasing evidence also highlights that
Barbara Honecker +2 more
wiley +1 more source
The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
OBJECTIVE: Chagas' disease has spread throughout Latin America because of the high rate of migration among these countries. Approximately 30% of Chagas' patients will develop cardiomyopathy, and 10% of these will develop severe cardiac damage leading to ...
Walace de Souza Pimentel +8 more
doaj +1 more source
The P2X7 Receptor and Its Relation to Neglected Tropical Diseases: Focusing on Chagas Disease
Chagas disease, caused by Trypanosoma cruzi, is a neglected tropical disease (NTD) that can lead to severe cardiac complications, including chronic Chagas cardiomyopathy. While NTDs are caused by a variety of pathogens—such as protozoa, bacteria, viruses, and helminths, Chagas disease remains underexplored, particularly regarding host immune responses.
Caroline de Souza Ferreira Pereira +2 more
wiley +1 more source
Serum Proteomic Signature of Human Chagasic Patients for the Identification of Novel Potential Protein Biomarkers of Disease [PDF]
Chagas disease is initiated upon infection by Trypanosoma cruzi. Among the health consequences is a decline in heart function, and the pathophysiological mechanisms underlying this manifestation are not well understood. To explore the possible mechanisms,
Garg, Nisha Jain +5 more
core +1 more source
Medical treatment of cardiac arrhythmias in Chagas'heart disease [PDF]
There are no controlled clinical trials evaluating drug therapy in patients with ventricular arrhythmias and chronic chagasic cardiomyopathy. Empirical treatment with disopyramide (400-1,000mg/d), phenytoin (4-6mg/d), mexiletine (600-1,200mg/d ...
De Paola, Angelo Amato Vincenzo +3 more
core +1 more source
Bufalin‐Induced Epithelial‐to‐Mesenchymal Transition in Kidney Epithelial Cells
ABSTRACT The kidney plays a central role in fluid, electrolyte, and blood pressure regulation, processes tightly coupled to Na⁺/K⁺‐ATPase activity. Beyond its canonical transport function, Na⁺/K⁺‐ATPase also acts as a signaling receptor for cardiotonic steroids (CTSs) such as bufalin, which have been implicated in fibrosis and epithelial‐to‐mesenchymal
Gabriela Morais de Oliveira Barros +3 more
wiley +1 more source
Cardiomyopathy protection in Chagas Disease [PDF]
There is some published evidence suggesting micro vascular endothelial dysfunction and dysautonomia involvement in Chagas disease in association with cardiomyocyte changes favoring disease progression. The combined treatment between angiotensin converting enzyme (ACE) inhibitor drugs; Simvastatin, muscarinic antibody immunoadsorbent together with ...
Mitelman, Jorge E., Gimenez, Luisa
openaire +2 more sources
Preoperative CT and 3D reconstruction demonstrating an inferior left ventricular aneurysm in a patient with a retrosternal gastric conduit, highlighting the rationale for choosing a left mini‐thoracotomy approach. ABSTRACT In patients with prior esophagectomy and retrosternal gastric conduit, conventional sternotomy may be hazardous.
Junya Kitaura +2 more
wiley +1 more source
The novel EPI‐VT‐Score accurately predicts the need for epicardial VT ablation using simple clinical, echocardiographic and ECG variables, optimizing patient selection and procedural outcomes. ABSTRACT Background Epicardial ventricular tachycardia (VT) ablation is a therapeutic option for drug‐refractory VT, particularly when endocardial ablation fails
Moneeb Khalaph +17 more
wiley +1 more source
Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy: Clinical Practice Update
Background: Chronic Chagas cardiomyopathy is an arrhythmogenic, fibrosis-prone form of heart failure that develops years after Trypanosoma cruzi infection. Standard therapy has largely been extrapolated from non-Chagas trials.
Katarzyna Skibicka +3 more
doaj +1 more source

